An observational study in Anxiety State, Sleep Disturbance and Alcohol Abuse, sponsored by University Hospital, Caen. Status unknown at 1 site in France. Open to participants aged 50 Years and older. Per ClinicalTrials.gov, last updated 2024-02-13.
Sponsored by University Hospital, Caen · Observational
The goal of MEM-ASA is to investigate the prevalence of anxiety/depression, sleep disturbances and alcohol use disorder in elderly with cognitive complaints.
In memory clinics of Normandy (France), all patients aged over 50 year-old are systematically questioned about anxiety, depression, sleep quality and alcohol use disorder. They also perform a neuropsychological assessment. Questionnaires are given to the patient and his/her caregiver to be filled in at home.
Levels of anxiety/depression, sleep quality and alcohol consumption are related to neuropsychological performance, diagnosis and responses to the questionaires.
324 studies on the registry are indexed under Dyssomnias; 51 are open to participants now.
This study's planned enrollment of 3,000 is above the median of 126 across 63 observational studies indexed under Dyssomnias.
Browse Dyssomnias studies →University Hospital, Caen is the lead sponsor of 505 studies on the registry; 80 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients of memory clinics in Normandy.
Exclusion Criteria:
-To be under tutorship or curatorship
Anxiety and depression
Responses to questions during anamnesis
Time frame: At inclusion
Sleep quality
Responses to questions during anamnesis
Time frame: At inclusion
Alcohol use disorder
Responses to questions during anamnesis
Time frame: At inclusion
Plan to share: No
No publications or documents are linked to this record.
This study is status unknown, as verified in Feb 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Caen